Potassium Iodide
ID: PotssiumIodideType: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFOFFICE OF THE ASSISTANT SECRETARY FOR ADMINISTRATION (ASA)PROGRAM SUPPORT CENTER ACQ MGMT SVCROCKVILLE, MD, 20857, USA

NAICS

Pharmaceutical and Medicine ManufacturingT (3254)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)
Timeline
    Description

    The Department of Health and Human Services, specifically the Office of the Assistant Secretary for Administration, is seeking qualified vendors to supply Potassium Iodide (KI) tablets, specifically the Thyrosafe brand or an equivalent, in blister packs of 20 tablets. The procurement requires a total quantity of 224,601 packages, each containing 20 tablets of 65mg KI, which is critical for public health preparedness in the event of nuclear emergencies. Interested small businesses are encouraged to participate, as this opportunity is set aside for total small business participation under FAR 19.5. For further details, vendors may contact Tim Bouchelle at Timothy.Bouchelle@hhs.gov or by phone at 443-947-6039.

    Point(s) of Contact
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Potassium Iodide
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0095 770-25-1-801-0132 -National CMOP FERROUS SULFATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to fulfill an emergency procurement for Ferrous Sulfate 324 mg EC Tablets, with a total quantity of 24,000 tablets to be delivered to multiple CMOP locations. The procurement requires compliance with the Drug Supply Chain Security Act (DSCSA) and mandates that all products be bar-coded according to industry standards, ensuring safety and traceability. This solicitation underscores the VA's commitment to providing quality pharmaceutical supplies for its healthcare services, with a submission deadline for quotes set for December 30, 2024, at 9:00 AM CST. Interested vendors must submit their proposals, including a signed SF1449, an Excel price schedule, and a state wholesale distributor license, to the primary contact, Michael W McAlhaney, at Michael.McAlhaney@va.gov.
    6515--36C261-25-AP-0840 Thyroid Captus 4000e System
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of a Nuclear Medicine Thyroid Uptake System, specifically targeting service-disabled veteran-owned small businesses (SDVOSB). The system is designed to measure radioactive tracer absorption in the thyroid, which is crucial for diagnosing thyroid-related health issues, and must include features such as DICOM compatibility, automated quality assurance, and customizable reporting capabilities. This acquisition aims to enhance diagnostic tools within the VA healthcare system while promoting veteran entrepreneurship, with proposals due by the specified closing date. Interested vendors should contact Contract Specialist Edward B. Hunter at Edward.Hunter@va.gov for further details and to ensure compliance with all submission requirements.
    Retail Pharmaceutical Prescription Fulfillment for Nashville Area Office Patients
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Indian Health Service, is seeking proposals for a Retail Pharmaceutical Prescription Fulfillment contract aimed at serving patients in the Nashville Area Office. This initiative is designed to enhance healthcare access for Native American communities by partnering with local pharmacies to provide primary and supplemental prescription coverage. The selected vendors will not only fulfill pharmaceutical needs but also contribute to corporate social responsibility efforts, promoting health equity within these communities. Interested parties can reach out to Paul Carr at paul.carr@ihs.gov or 615-467-1567 for further details, as the solicitation number is 285-25-RFQ-0001, with awards expected to be made following the presolicitation phase.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    Norgestimate/Ethinyl Estradiol Tablets
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) is soliciting offers for the supply of Norgestimate/Ethinyl Estradiol Tablets, a pharmaceutical product essential for oral contraceptive use. The procurement aims to establish a contract that outlines specific supply requirements, estimated quantities for multiple option years, and compliance with federal regulations, including ethical conduct and labor standards. This solicitation is critical for ensuring the availability of these contraceptive medications to support military personnel and their families. Interested contractors must submit their offers via the Defense Logistics Agency Internet Bid Board System (DIBBS) by January 21, 2025, and are encouraged to contact Kyle Lewicki at kyle.lewicki@dla.mil or Jason C. Wray at Jason.Wray@dla.mil for further information.
    Radiation Dosimetry
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Biomedical Advanced Research and Development Authority (BARDA), is seeking proposals for the development of standardized radiation dosimetry guidelines for nonclinical models used in radiation research. The primary objective is to create harmonized dosimetry practices across BARDA's research portfolio, which is crucial for ensuring consistent and comparable data in medical countermeasures against various threats, including chemical, biological, radiological, and nuclear hazards. This five-year contract includes a two-year base period with three optional one-year extensions, and it requires comprehensive services such as irradiator assessments and the fabrication of phantoms for animal models. Interested vendors should submit their proposals, including detailed organizational information and past performance documentation, by the specified deadlines, with the estimated award date projected for the third quarter of fiscal year 2025. For further inquiries, contact Audrey Glover at audrey.glover@hhs.gov or Joann Kambaja at Joann.Kambaja@hhs.gov.
    6550--Lab Supplies - (Radiopharm) |
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking vendors to provide Radiopharmaceutical I-123 Ioflupane (DaTscan) for the Philadelphia Veterans Affairs Medical Center. This Sources Sought Notice (Solicitation Number: 36C24425I0218) aims to gather information on suppliers' capabilities, including their DUNS Number and compliance with regulatory standards set by the Nuclear Regulatory Commission and FDA, to ensure timely delivery of essential radiopharmaceuticals for imaging services related to parkinsonian syndrome assessment. Interested vendors must be able to meet key delivery requirements, including next-day delivery during work hours and emergency deliveries within 45 minutes, with responses due by December 27, 2024. For further inquiries, vendors can contact Contracting Officer Amanda Saunders at amanda.saunders@va.gov or (412) 822-3731.
    6509--Warfarin Tablets (VA-25-00012328)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for the supply of Warfarin NA tablets under solicitation number VA-25-00012328. The objective of this procurement is to establish a reliable supply contract for Warfarin tablets to ensure consistent availability and pricing through the VA and Department of Defense's Pharmaceutical Prime Vendor Programs. This initiative is crucial for maintaining a steady supply of essential pharmaceuticals, thereby supporting the government’s commitment to high-quality patient care and regulatory compliance. Interested offerors must submit their proposals by December 31, 2024, at 2:30 PM CST, and should direct any inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    65--DANTROLENE SODIUM F
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), is seeking quotes for the procurement of Dantrolene Sodium F, a critical medical supply. The solicitation includes multiple line items, each requiring a quantity of three units to be delivered to the W05J Medical Maintenance Operations Division at Tobyhanna, with a delivery timeline of five days after order. Dantrolene Sodium is essential for treating malignant hyperthermia and is vital for patient safety in medical settings. Interested vendors must submit their quotes electronically, and any inquiries regarding the solicitation should be directed to the buyer via email at DibbsBSM@dla.mil.